Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literature

about

Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literature

Item

http://www.wikidata.org/entity/Q26749095

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Efficacy and safety of biphasi ...... es: A review of the literature

@ast

Efficacy and safety of biphasi ...... es: A review of the literature

@en

Efficacy and safety of biphasi ...... es: A review of the literature

@nl

type

Item

label

Efficacy and safety of biphasi ...... es: A review of the literature

@ast

Efficacy and safety of biphasi ...... es: A review of the literature

@en

Efficacy and safety of biphasi ...... es: A review of the literature

@nl

prefLabel

Efficacy and safety of biphasi ...... es: A review of the literature

@ast

Efficacy and safety of biphasi ...... es: A review of the literature

@en

Efficacy and safety of biphasi ...... es: A review of the literature

@nl

P1476

Efficacy and safety of biphasi ...... es: A review of the literature

@en

P2093

Ajay Kumar

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Comparison of thrice-daily lispro 50/50 vs thrice-daily lispro in combination with sulfonylurea as initial insulin therapy for type 2 diabetes

Evidence-based clinical use of insulin premixtures

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

Rising burden of obesity in Asia.

Prandial-basal insulin regimens plus oral antihyperglycaemic agents to improve mealtime glycaemia: initiate and progressively advance insulin therapy in type 2 diabetes

Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.

The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) trial: comparing the durability of lispro mix 75/25 and glargine

P304

288-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P3181

1946098

http://www.w3.org/2001/XMLSchema#string

P356

10.4103/2230-8210.179993

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27186543

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4855954

http://www.w3.org/2001/XMLSchema#string